EMA
safety_alert
· 2012-02-16
European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors
Summary
EMA informs about drug interaction between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitors, advising clinicians and patients on potential i…
Upgrade for the full analysis, importance score, and drug timeline.